DCLK1 isolation, identification, and targeting as an oncogenic driver indicates that DCLK1 may promote tumor heterogeneity and metastatic spread in colon and pancreas carcinomas [12–15]. This evidence concerns the gene DCLK1 and exocrine pancreatic carcinoma.